Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
You have to wonder though just how much cash the BoD might feel they need. I can't remember the share options for each but even a fairly moderate buy-out would probably make them millionaires many times over, enough to retire on and not have any worries.
Although I have a couple of mates who are now a year or two past retirement age and haven't yet retired, not because they need the money but because they enjoy their work and can't envisage what could take it's place.
At least twelve other companies (and probably many many more) are also on the 9th floor of 107 Cheapside.
https://suite.endole.co.uk/explorer/postcode/ec2v-6dn
May just be a forwarding address.
I raised a formal complaint with my provider back in June or thereabouts when they were unable to tell me what would happen with the shares, apart from I wouldn't be able to trade them It seemed to me bizarre that they didn't know, and couldn't even tell me if I could move the lot to another provider who can trade them. I've had apologies recently that their response has fallen outside their target timeframe because they still don't know.
So it seems to be a pretty unique situation, and they are as much in the dark as we are. I almost feel bad about raising the complaint.
One wonders how it will eventually be resolved. I suppose one day we will spot them being traded on NASDAQ and everything will fall into place.
And there's the problem, right there - nothing is normal around this company LOL
I hadn't imagined it might be sold at this stage but I suppose anything is possible. While I don't know the process, the delay in itself may or may not be a problem but the radio silence from the BoD is maybe more telling...?
Either way I am in no real rush to get it resolved, especially if it helps increase the value. :-)
Wonderful to see Tils picking up again, long may it continue!
I have a question re tax liability on Accustem, in a particular scenario. If, as has happened to others, my provider decides they can't allow Accustem to remain in my ISA and so give me the share certificate to put somewhere else, I presume at sale time the proceeds are liable for CGT and the effective purchase price would be £0?
I'd say it's almost inevitable it will be bought out at some point long before it ever reaches £40 or £50, or at least form a partnership where the other party takes on the lion's share of the effort (and therefore revenue). It isn't often that a 12 man company becomes a multi billion company, that's just too wide a jump - and big pharma is already adept at the stuff which we'd have to learn, or buy in (rules and regs, manufacturing and distribution, even financial management). Although UI suppose even that isn't so hard to do with a very narrow product range which people and governments will be clamouring for.
Whatever, to me £15 is a reasonable medium term target (pre Christmas, pre final trial outcomes) - and a partnership where we are given a lump of cash and some shares in a large pharma would do me. But DYOR...!!
Both phase 1B trials, one with end date Nov 22 the other Nov 23.
Undoubtedly this could be a right little earner if successful but after Phase 1B presumably comes Phases 2 and 3 so it will be a long wait.
This will be obvious to many, but for any who are holding TILS in an ISA do check now that your provider allows NASDAQ shares to be held. I have been wrangling with mine for many months to get an answer to what will happen to my Accustem shares, and I'm still none the wiser - except I won't be able to trade them. I can't get an answer to whether, if I move the whole ISA, the share allocation would move with it.
I'm not sure the OTC Pink would qualify as a recognised market (as it isn't really a true market) so at this moment in time they probably would say they aren't listed therefore are ineligible to be held in an ISA.
I've been in communication for months with Willis Owen but still no answer. Sounds similar to Barclays. All I know is that they won't allow NASDAQ shares in their ISA. I'm not sure whether they have a stocks and shares product to move them to so option 2 above would suit me best (unless they will transfer it directly to the likes of HL)
Steptoe's post has some irony :-)
"whinging about it here does nobody any good..... there is some chink of light somewhere, but tell us something, please!!!!"
Only teasing, I get your point but there is nowhere else to discuss it at the moment.
The latest Companies House info (from July) said there were 204m shares. https://tinyurl.com/y75mk969
Tripling the number of shares will dilute whatever value ours might have had.
Anyway that explains how it becomes an IPO - if they are offering 400m new shares for sale!!
And I'm sure the directors won't suffer any pain as a result of it!!
Fully aware of that Sharebel, I've been deeply involved in most of the discussions. I was responding to a query though, trying to be helpful.
However as I've previously said many times though, it isn't an IPO in the normal sense as that is when a company offers new shares for sale on the market. https://www.investopedia.com/terms/i/ipo.asp
So unless something happens there will be no new shares to offer in an Initial Public Offering so therefore it may not appear on the IPO list.